Smith Anderson is the largest business and litigation law firm headquartered in the Research Triangle region of North Carolinaone of the countrys fastest-growing hubs for innovation and entrepreneurship. At our core, we are passionate about advising dynamic regional, national and global companies and providing them unparalleled client service. Its that client focus which has proudly earned us accolades from leading legal publications, including our recognition as a Client Service A-Team firm by BTI Consulting Group for the past five years. We are a rare combination of legal and business innovators with a culture and heritage that has been shaped for more than 100 years.
The ideal candidate will have four to six years of leading law firm experience in tech transactions specific to the Life Science and/or AgTech industries. Experience should include drafting, reviewing, and negotiating the full range of technology transaction-related documents, including licensing and collaborations, product rights acquisition, joint ventures and co-development/co-promotion, supply, manufacturing, services, clinical trial agreements, sponsored research and university licenses, and material transfer and other building-block agreements. We expect a successful candidate to play a meaningful role in drafting and assisting in complex transactions with 9 and 10-figure bio-dollar valuations across a variety of therapeutic indications and platform technologies, while running smaller transactions, agreement review and client counseling with minimal supervision and oversight. Technology fluent in gene editing, crop trait development, immuno-oncology and gene therapy are all a plus.
Additionally, the candidate should exhibit the following skills and characteristics: